Get Yield And Growt...
Health Care: Health Services
Baxter International Inc. (BAX: NYSE)
$56.80 -0.27 | -0.47%
02/09/12 - 04:00 PM ET
2.42M / 3.73M
Vol / Avg. Vol:57.04 / 57.07
Open / Prev. Close:56.33 - 57.04
Today's Range:47.55 - 62.50
52 Wk Range:14.79%
Performance YTD:TheStreet Rating:
Portfolios with BAX
- Portfolio NameUser Type
- ContributorTop-Yielding Health Service...
- UserDividend Income 2011-11-23
- ProJohn Paulson
- ProBill Frels - Mairs & Po...
- ProJohn Buckingham - Al Frank ...
- ContributorDividend Stocks for the Wee...
- Contributor9 Stocks With Low Volatilit...
- UserCaboose
- ProTweedy Browne
- ContributorRocket Stocks for the Week ...
Latest BAX Headlines from TheStreet
- Baxter International's CEO Discusses Q4 2011 Results - Earnings Call Transcript 01.26.12 | 02:01 pm
- Baxter International Inc. Stock Upgraded (BAX) 12.26.11 | 06:12 am
- Eastman Kodak, Rambus: After-Hours Trading 12.22.11 | 05:12 pm
- Baxter International Inc. Stock Downgraded (BAX) 12.22.11 | 06:12 am
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 12.13.11 | 05:12 pm
- Baxter International Stock To Go Ex-dividend Tomorrow (BAX) 12.06.11 | 08:12 am
- Baxter International Inc. (BAX): Today's Featured Health Services Winner 11.29.11 | 04:11 pm
- 7 Stocks Dishing Out Bigger Dividends 11.18.11 | 11:11 am
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 11.16.11 | 05:11 pm
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 11.09.11 | 04:11 pm
Press Releases for BAX
- Prescribing Information: FOR TOPICAL USE ONLY. TISSEEL [Fibrin Sealant] Is Now Indicated For General Hemostasis In Surgery When Control Of Bleeding By Standard Surgical Techniques Is Ineffective Or Impractical. (Photo: Business Wire) - Business Wire 01.30.12 | 09:01 am
- Baxter Reports Sales And EPS For Fourth Quarter And Full-Year 2011 In Line With Guidance - Business Wire 01.26.12 | 07:01 am
- Mt. Ascutney Hospital And Health Center In Vermont Receives Prestigious $100,000 Foster G. McGaw Prize For Excellence In Community Service - Business Wire 01.24.12 | 09:01 am
- Baxter To Initiate Second Phase III Trial Studying GAMMAGARD LIQUID (IGIV) For The Treatment Of Alzheimer’s Disease - Business Wire 01.23.12 | 05:01 pm
- Baxter Appoints Jean-Luc Butel As President, International - Business Wire 01.09.12 | 04:01 pm
- Baxter Submits Application For FDA Approval Of GAMMAGARD LIQUID To Treat Multifocal Motor Neuropathy, A Degenerative Neurological Disorder - Business Wire 01.09.12 | 09:01 am
- Baxter Initiates Phase I Clinical Trial Of Longer-Acting Recombinant FVIII Treatment For Hemophilia A - Business Wire 01.05.12 | 08:01 am
- Baxter Recommends Shareholders Reject “Mini-Tender” Offer By TRC Capital - Business Wire 01.04.12 | 05:01 pm
- Baxter And Momenta Announce Collaboration To Develop And Commercialize Follow-On Biologics - Business Wire 12.22.11 | 04:12 pm
- Baxter To Present At The 30th Annual J.P. Morgan Health Care Conference - Business Wire 12.21.11 | 09:12 am
Partner Headlines for BAX
- 20 Low Volatility Stocks With Strong Sources Of Profitability - Seeking Alpha 01.29.12 | 08:01 am
- Morgan Keegan Reports Baxter to Initiate Second PIII Alzheimer's Disease Trial - Benzinga 01.24.12 | 09:01 am
- The Zacks Analyst Blog Highlights: JA Solar Holdings, China Sunergy, Coach, Baxter and Becton, Dickinson and Co. - Press Releases - Zacks 01.03.12 | 09:01 am
- Baxter Collaborates with Momenta - Analyst Blog - Zacks 12.30.11 | 03:12 pm
- 10 For 12: 10 Buy-Writes With A 12% Return In A Flat Market - Seeking Alpha 12.27.11 | 07:12 am
- RBC Capital Downgrades Baxter International to Outperform - Benzinga 12.20.11 | 09:12 am
- 5 Excellent John Paulson Picks That Are Inexpensive - Seeking Alpha 12.19.11 | 08:12 am
- Company News for December 14, 2011 - Corporate Summary - Zacks 12.14.11 | 10:12 am
- Notable Put Options Activity in Baxter International - Benzinga 12.07.11 | 01:12 pm
- Healthcare Sector: Noteworthy Buys And Sells By Insiders Last Week - Seeking Alpha 11.01.11 | 09:11 am
